AI & Bioinformatics: Universal Vaccine Development
Table of Contents
The ongoing threat of coronaviruses,highlighted by the COVID-19 pandemic,has spurred a global race to develop effective vaccines and therapies.While current vaccines primarily focus on generating antibodies against the viral “spike” protein, researchers are increasingly recognizing the crucial role of T cells in providing broader, more durable protection – potentially even against future variants and related viruses. A recent study from the La Jolla Institute for Immunology (LJI) has identified highly conserved regions within coronaviruses that consistently trigger a T cell response, offering a promising pathway towards a “universal” coronavirus vaccine.
The Power of T Cells: Beyond Antibodies
Antibodies are the first line of defense against viral infections, preventing viruses from entering cells. However, antibody responses can wane over time and may be less effective against rapidly evolving viruses like coronaviruses. T cells, on the other hand, offer a second layer of protection. They identify and destroy infected cells, helping to clear the virus and prevent severe disease.
Crucially, T cells can recognize viral components inside infected cells, meaning they aren’t solely reliant on the shape of the surface spike protein. This makes them potentially effective even when the virus mutates. Identifying which viral regions consistently trigger a strong T cell response across different coronaviruses is key to developing broadly protective immunity.
Researchers led by Alessandro Grifoni at LJI tackled this challenge by leveraging the power of the Immune Epitope Database (IEDB), a publicly available resource maintained by LJI scientists. The IEDB contains data on over 200 coronavirus epitopes – the specific parts of a virus that T cells recognize - identified by researchers worldwide.
“We knew there were T cell epitopes on the coronavirus spike protein, but pinpointing which ones sparked the strongest response was difficult,” explains grifoni. “We suspected there were other promising epitopes hidden within the existing data.”
To uncover these hidden targets, the team collaborated with virologists at the J. craig Venter Institute (JCVI).They employed a combination of bioinformatic tools, including artificial intelligence (AI), to compare epitopes from various coronaviruses, searching for similarities that indicated conserved regions. This analysis revealed specific sequences that consistently elicited a T cell response across different strains.
Targeting Beyond the Spike Protein for Broad Protection
The research revealed that T cells recognize epitopes both on the viral spike protein and in regions outside the spike protein. This is important because the spike protein is prone to mutations, while regions outside the spike tend to be more stable.
“The idea is that if a new coronavirus emerges, we might not be able to prevent infection entirely, but we might be able to protect from hospitalization,” Grifoni states.By targeting these conserved, non-spike epitopes, a future vaccine could potentially reduce the severity of illness even if the virus has mutated significantly. A cross-reactive T cell response, triggered by these conserved epitopes, could provide a crucial safety net.
A New Research Pipeline with Broad Implications
This study isn’t just about coronaviruses. Grifoni emphasizes that the research demonstrates the effectiveness of a new research pipeline that can be applied to other viral families.
“Our laboratory is collaborating with research groups interested in many different viral families,” she says. “We need to fill the knowledge gaps.”
This pipeline could be used to identify conserved T cell epitopes in other respiratory viruses like measles and Nipah virus, as well as viruses causing hemorrhagic fevers like Lassa and Junin virus. The ability to predict broadly protective T cell targets could revolutionize vaccine growth and pandemic preparedness.
Reference: Pereira Neto TA, Zmasek C, Avalos L, et al.Highly conserved Betacoronavirus sequences are broadly recognized by human T cells. Cell. doi: 10.1016/j.cell.2025.07.015